Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiersten

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
The Breast Journal|July 9, 2004
Relationship between mammographic breast density and tamoxifen in women with breast cancerAmy Tiersten, Yin Y Ng, Eliza Pile-Spellman, et al.
Cancer|January 28, 2003
A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinomaAmy D Tiersten, Caron Nelsen, Susan Talbot, et al.
Journal of Breast Cancer|November 6, 2020
Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based StudyBrittney S Zimmerman, Danielle Seidman, Natalie Berger, et al.
Gynecologic Oncology|February 10, 2004
Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinomaAmy D Tiersten, Meredith J Selleck, Dawn L Hershman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancerA D Seidman, A Tiersten, C Hudis, et al.
Transgender Health|March 1, 2021
The Mount Sinai Patient-Centered Preoperative Criteria Meant to Optimize Outcomes Are Less of a Barrier to Care Than WPATH SOC 7 Criteria Before Transgender-Specific SurgeryMax Lichtenstein, Laura Stein, Erin Connolly, et al.
Cancer|August 10, 2022
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancerRima Patel, Malin Hovstadius, Melanie W Kier, et al.
Transgender Health|January 16, 2023
The Mount Sinai Interdisciplinary Approach to Perioperative Care Improved the Patient Experience for Transgender IndividualsSangyoon J Shin, John Henry Pang, Linda Tiersten, et al.
Bone Marrow Transplantation|June 15, 2007
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancerL T Vahdat, D J Cohen, D Zipin, et al.
Oncology|August 23, 2021
Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31Natalie F Berger, Brittney S Zimmerman, Serena Tharakan, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
The Breast Journal|July 9, 2004
Relationship between mammographic breast density and tamoxifen in women with breast cancerAmy Tiersten, Yin Y Ng, Eliza Pile-Spellman, et al.
Cancer|January 28, 2003
A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinomaAmy D Tiersten, Caron Nelsen, Susan Talbot, et al.
Journal of Breast Cancer|November 6, 2020
Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based StudyBrittney S Zimmerman, Danielle Seidman, Natalie Berger, et al.
Gynecologic Oncology|February 10, 2004
Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinomaAmy D Tiersten, Meredith J Selleck, Dawn L Hershman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancerA D Seidman, A Tiersten, C Hudis, et al.
Transgender Health|March 1, 2021
The Mount Sinai Patient-Centered Preoperative Criteria Meant to Optimize Outcomes Are Less of a Barrier to Care Than WPATH SOC 7 Criteria Before Transgender-Specific SurgeryMax Lichtenstein, Laura Stein, Erin Connolly, et al.
Cancer|August 10, 2022
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancerRima Patel, Malin Hovstadius, Melanie W Kier, et al.
Transgender Health|January 16, 2023
The Mount Sinai Interdisciplinary Approach to Perioperative Care Improved the Patient Experience for Transgender IndividualsSangyoon J Shin, John Henry Pang, Linda Tiersten, et al.
Bone Marrow Transplantation|June 15, 2007
Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-gamma after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancerL T Vahdat, D J Cohen, D Zipin, et al.
Oncology|August 23, 2021
Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31Natalie F Berger, Brittney S Zimmerman, Serena Tharakan, et al.
Pageof 9